![Matej Mikulic](https://cdn.statcdn.com/static/../CMS/contactperson/ERI285_1713877581.png)
Drugs in development with potential to be first-in-class in 2016, by therapeutic area
This statistic shows the share of drugs in clinical development and regulatory review that have the potential to be first-in-class as of 2016, by therapeutic area. Some 86 percent of Alzheimer's disease drugs in clinical development had the potential to be first-in-class, as of 2016.